期刊文献+

1例儿童先天性粒细胞减少症的基因诊断 被引量:4

Genetic diagnosis of a child with congenital neutropenia
下载PDF
导出
摘要 目的应用基因诊断方法进一步提高对儿童先天性粒细胞减少症(CN)的认识和诊断水平。方法以1例儿童CN患者为研究对象,收集其临床资料、实验室检查结果,按序检测ELA2、GFI1、HAX1及WASp致病基因突变情况。依上述步骤对患儿分别进行疾病的临床及基因诊断并随访。结果参照诊断标准该患儿诊断为无遗传背景的散发性非综合征性CN;基因检测显示其携带已经报道的ELA2基因突变:c.164G>A;此外患儿中性粒细胞表面G-CSFR表达正常,G-CSFR胞内段未发现获得性截短性突变。结论基因突变检测证实1例儿童CN为ELA2基因突变所致,为该患儿未来的分组临床研究及基因治疗提供依据。 Objective To improve the understanding and diagnosis of congenital neutropenia (CN) in children by the use of gene mutation analysis. Methods Clinical data and laboratory results of a child suspected of CN were collected. ELA2, GFI1, HAX1, and WASp genes were sequenced. Clinical and genetic diagnosis of the child was made according to the above steps and a follow-up was carried out. Results The diagnosis ofa non-syndromic and sporadic CN with no genetic background was made for this patient according to the criteria; the mutation of c.164G〉A, p.Cys26Tyr in ELA2 which has been reported was found. Expression level of G-CSFR on the neutorphil from this patient was detected to be normal and no truncated mutation was found in the intracellular domain of G-CSFR. Conclusions The gene mutation analysis was performed for the genetic diagnosis of a child suspected of congenital neutropenia and ELA2 mutation of c.164G〉A, p.Cys26Tyr was confirmed in this case. The data provide the background for further clinical research as well as gene therapy in this patient.
出处 《临床儿科杂志》 CAS CSCD 北大核心 2013年第1期44-47,共4页 Journal of Clinical Pediatrics
关键词 先天性粒细胞减少症 基因诊断 ELA2基因 congenital neutropenia genetic diagnosis ELA2 gene
  • 相关文献

参考文献10

  • 1薛胜利,陈艳,邱桥成,冯宇峰,戴兰,乔曼,吴德沛.非综合征性先天性粒细胞减少症一例及基因诊断[J].中华内科杂志,2011,50(11):922-925. 被引量:3
  • 2Xue SL, Li JL, Zou JY, etal. A novel compound heterozy- gous HAX1 mutation in a Chinese patient with severe con- genital neutropenia and chronic myelomonocytic leukemia transformation but without neurodevelopmental abnormali- ties [J]. Haematologica, 2012, 97(2): 318-320.
  • 3薛胜利,戴兰,乔曼,陈艳,邱桥成,唐晓文,吴德沛.正常人外周血有核细胞膜表面G-CSFR的定量测定[J].中国免疫学杂志,2011,27(1):54-59. 被引量:6
  • 4Germeshausen M, Ballmaier M, Welte K. Incidence of CSF3R mutations in severe congenital neutropenia and relevance for leukemogenesis: results of a long-term survey [J]. Blood, 2007, 109(1): 93-99.
  • 5Dale DC, Person RE, Bolyard AA, et al. Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia [J]. Blood, 2000, 96(7): 2317-2322.
  • 6Klein C. Congenital neutropenia [J]. Hematol Am Soc Hematol Educ Program, 2009: 344-350.
  • 7Sinha S, Zhu QS, Romero G, etal. Deletional mutation of the external domain of the human granulocyte colony-stimulating factor receptor in a patient with severe chronic neutropenia re- fractory to granulocyte colony-stimulating factor [J]. J Pediatr Hematol Oncol, 2003, 25(10): 791-796.
  • 8Klein C. Molecular basis of congenital neutropenia [J]. Haematologica, 2009, 94(10): 1333-1336.
  • 9Horwitz MS, Duan Z, Korkmaz B, et al. Neutrophil elas- tase in cyclic and severe congenital neutropenia [J]. Blood, 2007, 109(5): 1817-1824.
  • 10Grenda DS, Murakami M, Ghatak J, et al. Mutations of the ELA2 gene found in patients with severe congenital neutropenia induce the unfolded protein response and cellular apoptosis [J]. Blood, 2007, 110(13): 4179-4187.

二级参考文献25

  • 1许洪志,仲春红,李爱,于媛,徐功立.再生障碍性贫血和骨髓增生异常综合征患者骨髓CD34^+细胞及其粒细胞集落刺激因子受体表达的研究[J].中华血液学杂志,2007,28(1):50-51. 被引量:9
  • 2Bocchietto E,Guglielmetti A,Silvagno F et al.Proliferative and migratory responses of murine microvascular endothelial cells to granulocyte-colony-stimulating factor[J].J Cell Physiol,1993;155:89-95.
  • 3Solaroglu I,Cahill J,Jadhav V et al.A Novel neuroprotectant granulocyte-colony stimulating factor[J].Stroke,2006;37:1123-1128.
  • 4Kimura A,Sultana T A.Granulocyte colony-stimulating factor receptors on CD34+ + cells in patients with myelodysplastic syndrome (MDS) and MDS-acute myeloid leukemia[J].Leuk Lymphoma,2004;45:1995-2000.
  • 5Sultana T A,Hironori H,Kinroito et al.Expression and functional analysis of granulocyte colony-stimulating factor receptors on CD34+ cells in patients with myelodysplastic syndrome(MDS) and MDS-acute myeloid leukemia[J].Br J Haematol,2003;121:63-75.
  • 6Avalos B R,Gasson J C,Hedvat C et al.Human granulocyte colony-stimulating factor:biologic activities and receptor characterization on hematopoietic cells and small cell lung cancer cell lines[J].Blood,1990;75:851-857.
  • 7Avalos B R.Molecular analysis of the granulocyte colony-stimulating factor receptor[J].Blood,1996;88:761-777.
  • 8Morikawa K,Morikawa S,Nakamura M et al.Characterization of granulocyte colony-stimulating factor receptor expressed on human lymphocytes[J].Br J Haematol,2002;118:296-304.
  • 9Sloand E M,Kim S,Maciejewski J P et al.Pharmacologic doses of granulocyte colony-stimulating factor affect cytokine production by lymphocytes in vitro and in vivo[J].Blood,2000;95(7):2269-2274.
  • 10Franzke A,Piao W,Lauber J et al.G-CSF as immune regulator in T cells expressing the G-CSF receptor:implications for transplantation and autoimmune diseases[J].Blood,2003;102:734-739.

共引文献6

同被引文献10

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部